NEGEV CAPITAL

negev-capital-logo

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.

#SimilarOrganizations #People #Financial #More

NEGEV CAPITAL

Social Links:

Industry:
Biotechnology Pharmaceutical

Founded:
2021-01-07

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS


Similar Organizations

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

navrogen-logo

Navrogen

Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.

Current Employees Featured

ken-belotsky_image

Ken Belotsky
Ken Belotsky Partner @ Negev Capital
Partner
2021-05-01

Investments List

Date Company Article Money raised
2022-02-10 Mindstate Design Labs Negev Capital investment in Seed Round - Mindstate Design Labs 11.5 M USD
2021-09-27 Delix Therapeutics Negev Capital investment in Series A - Delix Therapeutics 70 M USD
2021-09-21 MycroDose Therapeutics Negev Capital investment in Seed Round - MycroDose Therapeutics N/A
2021-08-15 Beckley Psytech Negev Capital investment in Series B - Beckley Psytech 58 M GBP
2021-06-29 NanoPsy Negev Capital investment in Seed Round - NanoPsy 500 K CAD

More informations about "Negev Capital"

Negev

Principal at Negev Capital . VP Ops at Levco Pharmaceuticals Ltd, CEO & VP Ops at Regenera Pharma LTD., Director and co-CEO at Targia Pharmaceuticals. PhD in cell biology from โ€ฆSee details»

Negev Capital - Crunchbase Investor Profile

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$21+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. We aim to support those early stage โ€ฆSee details»

Negev Capital Announces Final Close of $30M+ for Fund One, Set โ€ฆ

Jan 17, 2022 Negev Capital has been active in deploying Fund One to-date, with 40% of total capital allocated into 20 startups. Negev Capital continues to invest in pre-clinical and Phase 1 โ€ฆSee details»

Negev Capital - LinkedIn

Negev Capital is a psychedelic medical intervention investment fund with assets of USD$30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 โ€ฆSee details»

Negev Capital investment portfolio - PitchBook

Negev Capital General Information Company Description. Founded in 2021, Negev Capital Is a venture capital firm based in Grand Cayman, Cayman Islands. The firm prefers to invest in โ€ฆSee details»

Negev Capital - Investments, Portfolio & Company Exits

Jun 3, 2024 Negev Capital has made 15 investments. Their most recent investment was on Jun 3, 2024 , when Filament Health raised CA$2.3M . How many investments has this โ€ฆSee details»

Negev: funding psychedelic research in Europe and North America

Jul 6, 2023 Negev launched its first fund in 2021 with a broad focus, investing in companies with strong science and management teams, providing enough capital for the companies to pass โ€ฆSee details»

Negev Capital "Doubled Down" on Its Sizable Investment in Small โ€ฆ

Sep 21, 2021 Negev Capital has a broader strategic relationship with Small Pharma, and this latest investment increases the cumulative investment to (USD)$1 million. Negev Capital โ€ฆSee details»

Negev Capital - raizer.app

Negev Capital primarily target psychedelic companies with interventions that are at early-mid stages of clinical development. Learn which startups Negev Capital invests in, number of โ€ฆSee details»

Negev Capital Announces Final Close of $30M+ for Fund One, Set โ€ฆ

Jan 17, 2022 Negev Capital is an early stage VC fund. Negev Capital invests in companies that develop novel drugs for neuropsychiatric disorders, based on psychedelic compounds. 40% of โ€ฆSee details»

Negev Capital - Funding, Financials, Valuation & Investors

Jan 17, 2022 Negev Capital has raised a single venture fund, Fund One. This fund was announced on Jan 17, 2022 and raised a total of . obfuscated. obfuscated. Unlock for free . โ€ฆSee details»

Negev Capital Fund One: Performance - PitchBook

Negev Capital Fund One is an early-stage venture capital fund managed by Negev Capital. The fund is located in Grand Cayman, Cayman Islands. It targets medical sector and prefers to โ€ฆSee details»

Negev Capital Announces Major Milestones in UK, Canada, and

Mar 11, 2024 Negev Capital, a venture capital firm investing in the leading companies creating neuropsychiatric drugs based on psychedelic molecules, is proud to highlight recent โ€ฆSee details»

Gennady Drushlyak - Chief Financial Officer - Negev Capital

CFO Negev Capital · Finance professional with extensive expertise in turnaround management, M&A, investments, operating and project finance. Specialties: Operational and financial โ€ฆSee details»

Negev Capital Invests in Production and Distribution of Artisanal ...

Oct 12, 2021 Negev Capital is a psychedelic medical intervention investment fund with assets of USD$25+ million. Psyched is a Canadian-based supplements company focused on the โ€ฆSee details»

Negev Capital "Doubled Down" on Its Sizable Investment in Small โ€ฆ

Sep 21, 2021 Negev Capital is a psychedelic medical intervention investment fund with assets of USD$20+ million. We invest in drug discovery, with a focus on preclinical and/or Phase 1 โ€ฆSee details»

Negev Capital - Updates, News, Events, Signals & Triggers

Negev Capital primarily target psychedelic companies with interventions that are at early-mid stages of clinical development. Search Crunchbase. Start Free Trial . Chrome Extension. โ€ฆSee details»

Canada's Suncor says it could cut 2026 capital spending if low oil ...

6 hours ago CALGARY (Reuters) -Canada's second-largest oil producer Suncor Energy said on Wednesday a recent cost-cutting campaign had set it up well to weather lower global oil โ€ฆSee details»

Large portions of JNFโ€™s Canada Park destroyed by wildfires near โ€ฆ

1 day ago The organizationโ€™s campaign, which began in 1972, raised $15 million for the forested area, also known as Ayalon Park and Ayalon-Canada Park, which was completed in 1984. ...See details»

Bill Ackman to Harvard: When A University Becomes A "Political โ€ฆ

2 days ago Hedge fund manager Bill Ackman advised Harvard to treat President Trump's demands with respect and said the president is fair to challenge the university's tax-exempt โ€ฆSee details»

linkstock.net © 2022. All rights reserved